Edition:
India

Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

12.22HKD
15 Dec 2017
Change (% chg)

HK$-0.56 (-4.38%)
Prev Close
HK$12.78
Open
HK$12.62
Day's High
HK$12.80
Day's Low
HK$12.10
Volume
36,468,873
Avg. Vol
20,615,211
52-wk High
HK$12.96
52-wk Low
HK$5.23

Chart for

About

Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicines and Chemical Medicines segment is engaged in the manufacture, sales and distribution of modernized Chinese medicine products... (more)

Overall

Beta: 0.41
Market Cap(Mil.): HK$64,856.68
Shares Outstanding(Mil.): 7,412.19
Dividend: 0.02
Yield (%): 0.74

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Sino Biopharmaceutical Product Granted Drug Registration Approval By State FDA Of China​

* "TENOFOVIR DISOPROXIL FUMARATE TABLET" GRANTED DRUG REGISTRATION APPROVAL BY STATE FOOD AND DRUG ADMINISTRATION OF CHINA​

05 Dec 2017

BRIEF-Sino Biopharmaceutical posts 9-month ‍net profit attributable of RMB1.80​ bln

* ‍Declared payment of a third quarterly dividend of HK2 cents per share for three months ended 30 Sept​

09 Nov 2017

BRIEF-Sino Biopharmaceutical posts HY revenue of about RMB7,482.86 mln

* HY revenue was approximately RMB7,482.86 million, an increase of approximately 10.6 percent

21 Aug 2017

Earnings vs. Estimates